학술논문
A case of hepatitis B virus-infected patient with bevacizumab-related severe intratumor hemorrhage of large hepatocellular carcinoma (HCC) / アテゾリズマブとベバシズマブの併用療法に伴う腫瘍内の出血壊死により治療継続が困難となったHBV関連大型肝細胞癌の一例
Document Type
Journal Article
Author
Source
肝臓 / Kanzo. 2023, 64(8):382
Subject
Language
Japanese
ISSN
0451-4203
1881-3593
1881-3593
Abstract
The combination therapy of atezolizumab and bevacizumab is effective for unresectable hepatocellular carcinoma (HCC), while serious adverse effects can occasionally happen. Here we report a hepatitis B virus (HBV) infected patient with bevacizumab-related severe tumor hemorrhage of large HCC.